UPDATE: Morgan Keegan Raises Target On Emeritus Corporation (ESC)

Morgan Keegan is raising its price target on shares of Emeritus Corporation ESC to $31 from $24, and is reiterating its Outperform rating.

In a note to investors, Morgan Keegan writes, "We believe that investor sentiment has turned for senior housing operators, given the confluence of a recovering economy, very limited new supply, and stable labor costs. We are moving our valuation metric for Emeritus from a 1.0 multiple of CFFO growth to a 15% premium. Applied to our revised 2011 CFFO estimate, this yields a revised $31 price target."

Shares of ESC gained 61 cents yesterday to close at $24.50, a gain of 2.55%.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care FacilitiesMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!